[After TIA and stroke: a statin for secondary prevention?].
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000069059:Atorvastatin; D002986:Clinical Trials as Topic; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000401:mortality / Q000517:prevention & control*; D010919:Placebos; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D020521:Stroke / Q000401:mortality / Q000517:prevention & control*; D013997:Time Factors
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010919:Placebos; D011758:Pyrroles; D000069059:Atorvastatin